This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Renzi, D. Articles by Calabrò, A. Search for Related Content PubMed PubMed Citation Articles by Renzi, D. Articles by Calabrò, A.

(American Journal of Pathology. 2000;157:1511-1522.)
© 2000 American Society for Investigative Pathology

Regular Articles

Substance P (Neurokinin-1) and Neurokinin A (Neurokinin-2) Receptor Gene and Protein Expression in the Healthy and Inflamed Human Intestine

Daniela Renzi^*, Beatrice Pellegrini^*, Francesco Tonelli, Calogero Surrenti^* and Antonio Calabrò^*

From the Gastroenterology^*
and Surgery
Units, Department of Clinical Pathophysiology, University of Florence, Florence, Italy

Increasing evidence suggests that tachykinins are involved in the control of pathophysiological states, such as inflammation. The precise localization of tachykinin receptors is of paramount importance in the search for their possible physiological and pathological role; in this study, therefore, we attempted to define cellular sites of substance P (NK-1R) and neurokinin A (NK-2R) receptor expression in the healthy and the inflamed human intestine by in situ hybridization and immunohistochemistry. In the normal ileum and colon, NK-1R and NK-2R were localized to smooth muscle cells of the muscularis mucosae and propria and a few inflammatory cells of the lamina propria; NK-1R expression was also found in the muscular wall of submucosal blood vessels, enteric neurons and, to a lesser degree, in surface epithelial cells. Patients with Crohn’s disease and ulcerative colitis showed a dramatic increase in NK-1R density relative to controls, in both the inflamed and the uninvolved mucosa. Up-regulation of NK-1R was particularly evident on epithelial cells lining the mucosal surface and crypts, as well as on endothelial cells of capillaries and venules. Also, a marked increase in NK-2R expression was found in both groups of patients on inflammatory cells of the lamina propria, especially eosinophils. Our findings demonstrate that in the normal human intestine NK-1R and NK-2R are expressed in multiple cell types, which are endowed with different physiological functions; in addition, they demonstrate that both NK-1R and NK-2R are up-regulated in patients with Crohn’s disease and ulcerative colitis. Taken together, these observations may have important physiological and pathophysiological implications, and provide the rationale for the use of NK-1R and NK-2R antagonists in the treatment of inflammatory bowel disease.

This article has been cited by other articles:

				A. Gaman, M. C. Bucur, and B. Kuo Review: Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome Therapeutic Advances in Gastroenterology, May 1, 2009; 2(3): 169 - 181. [Abstract] [PDF]

				L. Liu, F. Shang, M. J. Morgan, D. W. King, D. Z. Lubowski, and E. Burcher Cyclooxygenase-Dependent Alterations in Substance P-Mediated Contractility and Tachykinin NK1 Receptor Expression in the Colonic Circular Muscle of Patients with Slow Transit Constipation J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 282 - 289. [Abstract] [Full Text] [PDF]

				M D Noble, J Romac, S R Vigna, and R A Liddle A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis Gut, November 1, 2008; 57(11): 1566 - 1571. [Abstract] [Full Text] [PDF]

				E. Burcher, F. Shang, F. J. Warner, Q. Du, D. Z. Lubowski, D. W. King, and L. Liu Tachykinin NK2 Receptor and Functional Mechanisms in Human Colon: Changes with Indomethacin and in Diverticular Disease and Ulcerative Colitis J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 170 - 178. [Abstract] [Full Text] [PDF]

				A. M. Scanu, T. J. Bull, S. Cannas, J. D. Sanderson, L. A. Sechi, G. Dettori, S. Zanetti, and J. Hermon-Taylor Mycobacterium avium Subspecies paratuberculosis Infection in Cases of Irritable Bowel Syndrome and Comparison with Crohn's Disease and Johne's Disease: Common Neural and Immune Pathogenicities J. Clin. Microbiol., December 1, 2007; 45(12): 3883 - 3890. [Abstract] [Full Text] [PDF]

				H.-W. Koon, D. Zhao, Y. Zhan, M. P. Moyer, and C. Pothoulakis Substance P mediates antiapoptotic responses in human colonocytes by Akt activation PNAS, February 6, 2007; 104(6): 2013 - 2018. [Abstract] [Full Text] [PDF]

				M. D. Noble, J. Romac, Y. Wang, J. Hsu, J. E. Humphrey, and R. A. Liddle Local disruption of the celiac ganglion inhibits substance P release and ameliorates caerulein-induced pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G128 - G134. [Abstract] [Full Text] [PDF]

				W. Cao, K. M. Harnett, and V. E. Pricolo NK2 Receptor-Mediated Spontaneous Phasic Contractions in Normal and Ulcerative Colitis Human Sigmoid Colon J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1349 - 1355. [Abstract] [Full Text] [PDF]

				H.-W. Koon, D. Zhao, Y. Zhan, S. H. Rhee, M. P. Moyer, and C. Pothoulakis Substance P Stimulates Cyclooxygenase-2 and Prostaglandin E2 Expression through JAK-STAT Activation in Human Colonic Epithelial Cells. J. Immunol., April 15, 2006; 176(8): 5050 - 5059. [Abstract] [Full Text] [PDF]

				I. Karagiannides, E. Kokkotou, M. Tansky, T. Tchkonia, N. Giorgadze, M. O'Brien, S. E. Leeman, J. L. Kirkland, and C. Pothoulakis Induction of colitis causes inflammatory responses in fat depots: Evidence for substance P pathways in human mesenteric preadipocytes PNAS, March 28, 2006; 103(13): 5207 - 5212. [Abstract] [Full Text] [PDF]

				H.-W. Koon, D. Zhao, Y. Zhan, S. Simeonidis, M. P. Moyer, and C. Pothoulakis Substance P-Stimulated Interleukin-8 Expression in Human Colonic Epithelial Cells Involves Protein Kinase C{delta} Activation J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1393 - 1400. [Abstract] [Full Text] [PDF]

				H.-W. Koon, D. Zhao, X. Na, M. P. Moyer, and C. Pothoulakis Metalloproteinases and Transforming Growth Factor-{alpha} Mediate Substance P-induced Mitogen-activated Protein Kinase Activation and Proliferation in Human Colonocytes J. Biol. Chem., October 29, 2004; 279(44): 45519 - 45527. [Abstract] [Full Text] [PDF]

				N Kihara, S G de la Fuente, K Fujino, T Takahashi, T N Pappas, and C R Mantyh Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats Gut, May 1, 2003; 52(5): 713 - 719. [Abstract] [Full Text]

				S. Simeonidis, I. Castagliuolo, A. Pan, J. Liu, C.-C. Wang, A. Mykoniatis, A. Pasha, L. Valenick, S. Sougioultzis, D. Zhao, et al. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter PNAS, March 4, 2003; 100(5): 2957 - 2962. [Abstract] [Full Text] [PDF]

				P T Schmidt, M Lordal, B Gazelius, and P M Hellstrom Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans Gut, January 1, 2003; 52(1): 53 - 56. [Abstract] [Full Text] [PDF]

				L. Liu, F. Shang, I. Markus, and E. Burcher Roles of Substance P Receptors in Human Colon Circular Muscle: Alterations in Diverticular Disease J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 627 - 635. [Abstract] [Full Text] [PDF]

				Y. Hosoda, S.-I. Karaki, Y. Shimoda, and A. Kuwahara Substance P-evoked Cl- secretion in guinea pig distal colonic epithelia: interaction with PGE2 Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G347 - G356. [Abstract] [Full Text] [PDF]

				E. H. Kamp, D. R. Beck, and G. F. Gebhart Combinations of Neurokinin Receptor Antagonists Reduce Visceral Hyperalgesia J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 105 - 113. [Abstract] [Full Text] [PDF]